Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Biohaven PharmaceuticalArQuleKaruna TherapeuticsEpizymeRa Pharmaceuticals
SymbolNYSE:BHVNNASDAQ:ARQLNASDAQ:KRTXNASDAQ:EPZMNASDAQ:RARX
Price Information
Current Price$35.28$20.00$70.81$17.78$46.90
52 Week RangeBuyHoldBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price Target$70.36$17.50$108.88$33.00$47.38
% Upside from Price Target99.44% upside-12.50% downside53.76% upside85.60% upside1.01% upside
Trade Information
Market Cap$2.09 billion$2.42 billion$1.85 billion$1.78 billion$2.22 billion
Beta0.62.49N/A2.41.33
Average Volume1,034,9235,269,080333,0251,130,0521,369,490
Sales & Book Value
Annual RevenueN/A$25.76 millionN/A$23.80 million$3 million
Price / SalesN/A93.85N/A75.28739.93
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.14) per share$0.72 per shareN/A$3.22 per share$5.56 per share
Price / BookN/A27.78N/A5.528.44
Profitability
Net Income$-528,800,000.00$-15,480,000.00N/A$-170,290,000.00$-102,690,000.00
EPS($10.91)($0.16)($3.68)($1.93)($2.31)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-805.61%N/A-715.53%N/A
Return on Equity (ROE)-428.84%-33.10%N/A-58.26%-44.61%
Return on Assets (ROA)-111.58%-26.87%N/A-44.15%-41.60%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.08%N/A0.14%0.01%
Current Ratio4.96%8.27%132.76%11.61%14.78%
Quick Ratio4.96%8.27%106.93%11.61%14.79%
Ownership Information
Institutional Ownership Percentage84.12%74.63%54.31%90.70%N/A
Insider Ownership Percentage23.90%13.80%N/A16.60%4.30%
Miscellaneous
Employees63361312472
Shares Outstanding58.29 million120.87 million26.08 million100.77 million47.33 million
Next Earnings Date5/5/2020 (Estimated)4/29/2020 (Estimated)6/23/2020 (Estimated)5/4/2020 (Estimated)5/14/2020 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel